Precigen stock price
프레시젠NASDAQ:PGEN · Nasdaq · HealthcareToday's signals · Near 52-week high, MA aligned
Signal details →Precigen last closed at $8.54 (+4.02%) on 2026-10-02. Signals today: Near 52-week high, MA aligned. Listed on Nasdaq. Trailing 12 months PER is -22.4×. Its overall grade ranks 123 of 739 stocks in Healthcare.
About this company
Precigen last closed at $8.54 (+4.02%) on 2026-10-02. Signals today: Near 52-week high, MA aligned. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A · 123/739
Valuation grade C
Related stocks
- Johnson & JohnsonCustomer
세포·유전자치료 및 바이오 파트너십/사업화 측면에서 연관성이 큰 대형 제약사
- AstraZenecaCustomer
바이오 신약 개발·라이선스/협력 가능성이 큰 글로벌 제약사
- Merck & Co.Customer
면역항암·세포치료 플랫폼과 연계될 수 있는 대형 글로벌 제약사
ETFs holding this stock
Virtus LifeSci Biotech Products ETF · First Trust Small Cap Growth AlphaDEX Fund
Details →About Precigen
- What technical signals does Precigen (PGEN) have?
- Precigen current technical signals: MA alignment (score 0.94).
- Is Precigen a cup-and-handle pattern?
- No. Precigen has no valid Cup signal right now.
- What published figures are available for Precigen?
- Market cap: $3.02B. Trailing 12 months PER: -22.4×. Latest quarter PBR: 81.07×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-03 dataset
Turn what you saw on this name into a strategy
Ask Q about Precigen, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).